Treating multiple myeloma in the era of new drugs: What is the right choice?

被引：1
|
作者：
Perego, Gianluca [1 ]
Paris, Laura [2 ]
Nozza, Silvia [1 ]
Stefanoni, Paola [2 ]
Franzin, Michela [1 ]
机构：
[1] ASST Papa Giovanni XXIII, Pharm Unit, Bergamo, Italy
[2] ASST Papa Giovanni XXIII, Dept Oncol & Hematol, Bergamo, Italy
来源：
JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2023年 / 29卷 / 05期
关键词：
New drugs; newly diagnosed multiple myeloma; relapsed and refractory multiple myeloma; ELIGIBLE PATIENTS; OPEN-LABEL; DARATUMUMAB; DEXAMETHASONE; BORTEZOMIB;
D O I：
10.1177/10781552231176499
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1234 / 1236
页数：3
相关论文
共 50 条
  • [31] Outcome and Toxicity in the Modern Era of New Drugs for Multiple Myeloma: A Reappraisal for Comparison With Future Investigational Trials
    Offidani, Massimo
    Leoni, Pietro
    Corvatta, Laura
    Polloni, Claudia
    Gentili, Silvia
    Liberati, Anna Marina
    Pulini, Stefano
    Gozzetti, Alessandro
    Ballanti, Stelvio
    Nozzoli, Chiara
    Palumbo, Antonio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (05): : 353 - 360
  • [32] Rediscovering hemostasis abnormalities in multiple myeloma: The new era
    Huang, Yudie
    Wang, Chongyu
    Wang, Hua
    Liu, Hong
    Zhou, Lu
    HELIYON, 2024, 10 (13)
  • [33] Monoclonal antibodies - A new era in the treatment of multiple myeloma
    Jelinek, Tomas
    Hajek, Roman
    BLOOD REVIEWS, 2016, 30 (02) : 101 - 110
  • [34] Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
    Zhou, Xiang
    Einsele, Hermann
    Danhof, Sophia
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [35] Multiple myeloma and kidney transplantation: the beginning of a new era
    Van den bosch, Ines
    Sprangers, Ben
    Gertz, Morie
    CLINICAL KIDNEY JOURNAL, 2019, 12 (02) : 213 - 215
  • [36] What Is New in the Treatment of Smoldering Multiple Myeloma?
    Bolli, Niccolo
    Sgherza, Nicola
    Curci, Paola
    Rizzi, Rita
    Strafella, Vanda
    Delia, Mario
    Gagliardi, Vito Pier
    Neri, Antonino
    Baldini, Luca
    Albano, Francesco
    Musto, Pellegrino
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (03) : 1 - 17
  • [37] Etiology of multiple myeloma: What's new
    Berenson, JR
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 2 - 9
  • [38] Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab
    Afifi, Salma
    Michael, Angela
    Lesokhin, Alexander
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (07) : 555 - 568
  • [39] Old and new generation immunomodulatory drugs in multiple myeloma
    Derudas, Daniele
    Capraro, Francesca
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2020, 62 (04) : 207 - 219
  • [40] Is there a role for new drugs with alkylating properties in multiple myeloma?
    Mateos, Maria-Victoria
    Gonzalez-Calle, Veronica
    LANCET HAEMATOLOGY, 2020, 7 (05): : E357 - E359
12345